Applying a daily emollient on infants younger than aged 9 weeks reduced the risk for atopic dermatitis by 16% at 24 months ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

SMX gains national spotlight as key player in securing defense supply chains – media recognition signals growing market relevance NEW YORK, NY / ACCESS Newswire / July 21, 2025 / A recent editorial ...

Boehringer Ingelheim & LEO Pharma partner to commercialize and further develop Spevigo: Ingelheim, Germany Wednesday, July 16, 2025, 15:00 Hrs [IST] Boehringer Ingelheim, a biopha ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission to guide clinicians, patients, researchers, and payers.

Vyne has given up hope of resuming a psoriasis trial of its BET inhibitor under an FDA hold, but the biotech plans to persevere with the candidate.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Chronic plaque psoriasis is an immune-mediated, chronic, inflammatory skin disease, which can impair quality of life and social interaction. Disease severity can be classified by the psoriasis area ...

Plaque psoriasis is an autoimmune disease that causes thick, scaly patches of skin. The plaques can occur anywhere on the body, but they most commonly appear on the scalp, knees, elbows and torso.

After completing his fifth NBA season, Ball debuted a full-body tattoo expansion this week. The former All-Star who is known for his style now sports two full arm sleeves that connect seamlessly ...